Visaris Americas, a provider of digital radiography (DR) technology and PACS workflow solutions for the medical diagnostics market, announced that it has received US Food and Drug Administration (FDA) 510(k) clearance on its software, flat panel detectors, and various hardware offerings.
The company’s Avanse software is central to its Visaris360 software products. Avanse is designed to integrate with the latest generation of flat panel detectors, enabling facilities to more easily transition to a single software platform and reducing training and overall support costs, while providing integration and increased productivity of the entire x-ray department. As part of the company’s Vision Family of fully-integrated DR systems, the Avanse acquisition software platform is said to provide full interoperability, improving the quality and reproducibility of clinical images, while further reducing examination time.
The company reports that the FDA clearance will facilitate its goal of providing a comprehensive digital imaging and workflow solution to a multitiered market segment. For more information about the Avanse DR software and other products, visit the Visaris Americas website.
